PL341062A1 - Novel applications of compounds exhibiting antipsoric properties - Google Patents

Novel applications of compounds exhibiting antipsoric properties

Info

Publication number
PL341062A1
PL341062A1 PL98341062A PL34106298A PL341062A1 PL 341062 A1 PL341062 A1 PL 341062A1 PL 98341062 A PL98341062 A PL 98341062A PL 34106298 A PL34106298 A PL 34106298A PL 341062 A1 PL341062 A1 PL 341062A1
Authority
PL
Poland
Prior art keywords
antipsoric
properties
compounds exhibiting
novel applications
novel
Prior art date
Application number
PL98341062A
Other languages
English (en)
Inventor
Don E Griswold
Siegfried Benjamin Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL341062A1 publication Critical patent/PL341062A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98341062A 1997-10-17 1998-10-16 Novel applications of compounds exhibiting antipsoric properties PL341062A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (1)

Publication Number Publication Date
PL341062A1 true PL341062A1 (en) 2001-03-26

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341062A PL341062A1 (en) 1997-10-17 1998-10-16 Novel applications of compounds exhibiting antipsoric properties

Country Status (18)

Country Link
EP (1) EP1030666A4 (tr)
JP (1) JP2001520196A (tr)
KR (1) KR20010031149A (tr)
CN (1) CN1306426A (tr)
AR (1) AR015966A1 (tr)
AU (1) AU740875B2 (tr)
BR (1) BR9814080A (tr)
CA (1) CA2306985A1 (tr)
CO (1) CO4810374A1 (tr)
CZ (1) CZ20001376A3 (tr)
HU (1) HUP0003792A3 (tr)
IL (1) IL135581A0 (tr)
NO (1) NO20001847D0 (tr)
NZ (1) NZ503551A (tr)
PL (1) PL341062A1 (tr)
TR (1) TR200001040T2 (tr)
WO (1) WO1999020280A1 (tr)
ZA (1) ZA989450B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520386A (ja) 2001-01-31 2004-07-08 ファイザー・プロダクツ・インク Ｐｄｅ４アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
OA12542A (en) 2001-01-31 2006-06-05 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of PDE4isozymes.
KR20030070150A (ko) 2001-01-31 2003-08-27 화이자 프로덕츠 인크. Ｐｄｅ4 이소자임 억제제로서 유용한 에테르 유도체
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
WO2005007161A1 (ja) * 2003-07-17 2005-01-27 Santen Pharmaceutical Co., Ltd. ピペリジン誘導体を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
HRP20130406T1 (hr) 2004-02-14 2013-06-30 Glaxosmithkline Intellectual Property Development Limited Medikamenti s aktivnošä†u prema receptoru hm74a
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
JP5112316B2 (ja) 2005-08-10 2013-01-09 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 選択的ｈｍ７４ａアゴニストとしてのキサンチン誘導体
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2007218725B2 (en) * 2006-02-21 2011-12-01 Eisai R & D Management Co., Ltd. 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
CN101687819B (zh) 2007-08-17 2013-03-20 卫材R&D管理有限公司 外用剂
CN101687820B (zh) 2007-08-17 2012-07-25 卫材R&D管理有限公司 喹唑啉衍生物的制造方法
JP5985475B2 (ja) * 2011-06-28 2016-09-06 田辺三菱製薬株式会社 新規医薬組成物
SG11201705889VA (en) 2015-01-30 2017-08-30 Shanton Pharma Co Ltd Prevention or Treatment of Uratic or Gouty Diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE194345T1 (de) * 1990-12-21 2000-07-15 Beecham Group Plc Xanthinderivate
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
US6020340A (en) * 1996-05-15 2000-02-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridines
US6143759A (en) * 1997-03-07 2000-11-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrazoles
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
AU8106598A (en) * 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
EP1030666A4 (en) 2002-10-16
AR015966A1 (es) 2001-05-30
TR200001040T2 (tr) 2001-01-22
CO4810374A1 (es) 1999-06-30
NZ503551A (en) 2002-05-31
WO1999020280A1 (en) 1999-04-29
HUP0003792A3 (en) 2001-12-28
BR9814080A (pt) 2000-09-26
NO20001847L (no) 2000-04-10
CZ20001376A3 (cs) 2002-06-12
AU1093899A (en) 1999-05-10
CN1306426A (zh) 2001-08-01
ZA989450B (en) 1999-04-19
AU740875B2 (en) 2001-11-15
IL135581A0 (en) 2001-05-20
NO20001847D0 (no) 2000-04-10
EP1030666A1 (en) 2000-08-30
CA2306985A1 (en) 1999-04-29
JP2001520196A (ja) 2001-10-30
KR20010031149A (ko) 2001-04-16
HUP0003792A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
PL341672A1 (en) Derivatives of benzothiazepin exhibiting hypolipidemic properties
IL136086A0 (en) New composition of matter
ZA984127B (en) New composition of matter
GB2330182B (en) Manufacture of gaskets
PL331470A1 (en) Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications
GB9404703D0 (en) Production of difluoromethane
AU3057299A (en) Sustained-release composition containing cefaclor
PL321546A1 (en) Novel applications of lysozime dimers
PL342733A1 (en) Biocement of improved properties
ZA985760B (en) Glass composition of the silica-soda-lime-type
GB9722451D0 (en) The manufacture of gaskets
PL328669A1 (en) Novel applications of pyrrole derivatives
ZA9810718B (en) Novel crystal modification of thiazine-indigo
IL130670A0 (en) Manufacture of elongate members
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB9416962D0 (en) Production of difluoromethane
GB9706377D0 (en) Novel compound
PL319263A1 (en) Novel derivative of pyrimidinylcarbazole
GB9722026D0 (en) Use of compounds
GB9306089D0 (en) Production of difluoromethane
GB9324777D0 (en) Production of difluoromethane
GB9306079D0 (en) Production of difluoromethane
GB9306072D0 (en) Production of difluoromethane
AUPO627197A0 (en) Applications of LED's
GB9810260D0 (en) Novel use of quinine